HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Symrise Appealing REACH Animal Testing Mandates To EU High Court; Unilever, PETA To Intervene

Executive Summary

The EU Court of Justice will consider whether the EU General Court erred in affirming ECHA decisions that require Symrise to conduct new animal testing to assess the reproductive and other health effects of UV filters homosalate and octisalate. In recent failed bids for interim relief, Symrise argued that the animal testing is likely to cause “irreparable damage” to its interests.

You may also be interested in...



EU High Court Is ‘Indifferent To Modern Values’; Reactions To Cosmetic Ingredient Animal-Testing Decision

The Cosmetic Products Regulation’s “once groundbreaking” ban is now worthless, says PETA, which supported Symrise in two cases challenging animal testing required by the European Chemicals Agency for cosmetics-only ingredients under REACH. Cruelty Free Europe, the European Federation for Cosmetic Ingredients, and Unilever also intervened on Symrise’s behalf.

Cosmetics Europe Expanding To Meet Historic Challenges: ‘There’s Never Been A Time Like This’

Director-general John Chave discusses regulatory heavy-handedness in the EU, implications for animal testing, declining European investment, and Cosmetics Europe’s message to policymakers going into the 2024 EU elections and beyond.

EU Starts On Proposal For Tackling ‘Most Harmful’ Chemicals Under Revised Cosmetics Reg

The European Commission is preparing a legal proposal to revise the Cosmetic Products Regulation in line with Green Deal objectives, including the phasing out of chemicals deemed “most harmful." Cosmetics Europe director-general John Chave discusses the problematic approach, possible impacts, and the bizarre and unintended results it could produce.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151710

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel